TRIM33 and kidney cancer: In order to examine the effect of TRIM33, we used the lentiviral transfection technology to establish two kidney cancer cell lines that overexpress TRIM33, and detected the efficiency of overexpression by qRT-PCR and western blotting (Figures 3(d)–3(f)).